Related Experiment Video
Updated: Jun 10, 2026
06:07
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Therapeutic options for HIV-associated lymphomas.
Michele Spina1, Annunziata Gloghini, Umberto Tirelli
1Department of Medical Oncology, Centro di Riferimento Oncologico Aviano, Istituto Nazionale Tumori, Italy.
Expert Opinion on Pharmacotherapy
|August 24, 2010
Summary
Treatment for HIV-associated lymphomas needs new options. Rituximab plus chemotherapy is recommended for diffuse large B-cell lymphomas, and aggressive chemotherapy is feasible for HIV-associated Burkitt
Area of Science:
- Oncology
- Infectious Diseases
- Hematology
Background:
- HIV-associated lymphomas exhibit distinct clinical features and natural history compared to the general population.
- Treatment intensification has not improved outcomes, highlighting the need for novel therapeutic strategies.
Purpose of the Study:
- To review current treatment strategies and prognostic factors for HIV-associated lymphomas.
- To identify challenges and future directions in managing these rare malignancies.
Main Methods:
- Comprehensive literature review of studies from 1995 to the present.
- Focus on treatment approaches and their prognostic significance in HIV-lymphoma patients.
Main Results:
- Identifying prognostic factors for rare HIV-associated lymphomas requires multi-institutional tissue banks.
- The rarity of primary effusion and oral plasmablastic lymphomas complicates large prospective studies and personalized therapy.
Conclusions:
- HIV-associated lymphomas remain a critical area for clinical research with no established standard therapies.
- Rituximab plus chemotherapy is recommended for most HIV-positive diffuse large B-cell lymphoma patients.
- Intensive chemotherapy regimens have shown feasibility in HIV-associated Burkitt's lymphomas.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...